publication date: Jan. 17, 2014


CDC: Lung Cancer Rates Drop Following Anti-Smoking Efforts

The rate of new lung cancer cases decreased among men and women from 2005 to 2009, largely due to tobacco control efforts, according to a report from the Centers for Disease Control and Prevention.

The study found that lung cancer incidence rates went down 2.6 percent per year among men, from 87 to 78 cases per 100,000 men and 1.1 percent per year among women, from 57 to 54 cases per 100,000 women.

The fastest drop was among adults aged 35-44 years, decreasing 6.5 percent per year among men and 5.8 percent per year among women. Lung cancer incidence rates decreased more rapidly among men than among women in all age groups. Among adults aged 35-44 years, men had slightly lower rates of lung cancer incidence than women. Because smoking behaviors among women are now similar to those among men, women are now experiencing the same risk of lung cancer as men.

For the Morbidity and Mortality Weekly Report, CDC used data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results program to assess lung cancer incidence rates and trends.

“These dramatic declines in the number of young adults with lung cancer show that tobacco prevention control programs work – when they are applied,” said CDC Director Tom Frieden.

Lung cancer incidence decreased among men in all U.S. census regions and 23 states, and decreased among women in the South and West and seven states. Rates were stable in all other states.

In 2010, states appropriated 2.4 percent of their tobacco revenues for tobacco control. The study indicated that continued attention to local, … Continue reading 40-03 Tobacco Control

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.